358 related articles for article (PubMed ID: 38799237)
1. New advances of adiponectin in regulating obesity and related metabolic syndromes.
Han Y; Sun Q; Chen W; Gao Y; Ye J; Chen Y; Wang T; Gao L; Liu Y; Yang Y
J Pharm Anal; 2024 May; 14(5):100913. PubMed ID: 38799237
[TBL] [Abstract][Full Text] [Related]
2. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling.
Shabalala SC; Dludla PV; Mabasa L; Kappo AP; Basson AK; Pheiffer C; Johnson R
Biomed Pharmacother; 2020 Nov; 131():110785. PubMed ID: 33152943
[TBL] [Abstract][Full Text] [Related]
3. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD).
Thondam SK; Cuthbertson DJ; Wilding JPH
Peptides; 2020 Mar; 125():170208. PubMed ID: 31759125
[TBL] [Abstract][Full Text] [Related]
4. Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions.
Adolph TE; Grander C; Grabherr F; Tilg H
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758929
[TBL] [Abstract][Full Text] [Related]
5. [METABOLIC FEATURES OF ADIPOSE TISSUE AND CLINICAL SIGNIFICANCE OF ADIPOKINS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (REVIEW)].
Pivtorak K; Yakovleva O; Pivtorak N; Fedzhaga I; Doroshkevich I
Georgian Med News; 2021; (316-317):135-141. PubMed ID: 34511460
[TBL] [Abstract][Full Text] [Related]
6. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?
Finelli C; Tarantino G
World J Gastroenterol; 2013 Feb; 19(6):802-12. PubMed ID: 23430039
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of diet-induced metabolic syndrome and fatty liver with sitagliptin via regulation of adipose tissue inflammation and hepatic Adiponectin/AMPK levels in mice.
Prakash S; Rai U; Kosuru R; Tiwari V; Singh S
Biochimie; 2020 Jan; 168():198-209. PubMed ID: 31715215
[TBL] [Abstract][Full Text] [Related]
8. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.
Polyzos SA; Kountouras J; Zavos C; Tsiaousi E
Diabetes Obes Metab; 2010 May; 12(5):365-83. PubMed ID: 20415685
[TBL] [Abstract][Full Text] [Related]
9. Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.
Rajesh Y; Sarkar D
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671547
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin: A potential therapeutic target for metabolic syndrome.
Ghadge AA; Khaire AA; Kuvalekar AA
Cytokine Growth Factor Rev; 2018 Feb; 39():151-158. PubMed ID: 29395659
[TBL] [Abstract][Full Text] [Related]
11. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
Matsuda M; Shimomura I
Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
[TBL] [Abstract][Full Text] [Related]
12. Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression.
Chang ML; Yang Z; Yang SS
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167521
[TBL] [Abstract][Full Text] [Related]
13. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
Larter CZ; Chitturi S; Heydet D; Farrell GC
J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
[TBL] [Abstract][Full Text] [Related]
14. Silencing the Adipocytokine NOV: A Novel Approach to Reversing Oxidative Stress-Induced Cardiometabolic Dysfunction.
Waldman M; Singh SP; Shen HH; Alex R; Rezzani R; Favero G; Hochhauser E; Kornowski R; Arad M; Peterson SJ
Cells; 2022 Sep; 11(19):. PubMed ID: 36231029
[TBL] [Abstract][Full Text] [Related]
15. Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines.
Hui E; Xu A; Bo Yang H; Lam KS
J Diabetes Investig; 2013 Sep; 4(5):413-25. PubMed ID: 24843689
[TBL] [Abstract][Full Text] [Related]
16. The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines.
Field BC; Gordillo R; Scherer PE
Front Endocrinol (Lausanne); 2020; 11():569250. PubMed ID: 33133017
[TBL] [Abstract][Full Text] [Related]
17. The association of the adipokine zinc-alpha2-glycoprotein with non-alcoholic fatty liver disease and related risk factors: A comprehensive systematic review.
Namkhah Z; Naeini F; Ostadrahimi A; Tutunchi H; Hosseinzadeh-Attar MJ
Int J Clin Pract; 2021 Jul; 75(7):e13985. PubMed ID: 33404166
[TBL] [Abstract][Full Text] [Related]
18. The ketogenic diet prevents steatosis and insulin resistance by reducing lipogenesis, diacylglycerol accumulation and protein kinase C activity in male rat liver.
Jani S; Da Eira D; Stefanovic M; Ceddia RB
J Physiol; 2022 Sep; 600(18):4137-4151. PubMed ID: 35974660
[TBL] [Abstract][Full Text] [Related]
19. Adipose Signals Regulating Distal Organ Health and Disease.
Gilani A; Stoll L; Homan EA; Lo JC
Diabetes; 2024 Feb; 73(2):169-177. PubMed ID: 38241508
[TBL] [Abstract][Full Text] [Related]
20. Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis.
Tilg H
Curr Pharm Des; 2010 Jun; 16(17):1893-5. PubMed ID: 20370678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
